Literature DB >> 27018118

Statin Use and Survival in Resectable Pancreatic Cancer: Confounders and Mechanisms.

Livia Archibugi1, Gabriele Capurso1, Gianfranco Delle Fave1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018118     DOI: 10.1038/ajg.2015.412

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.

Authors:  Felix Lötsch; Oliver Königsbrügge; Florian Posch; Christoph Zielinski; Ingrid Pabinger; Cihan Ay
Journal:  Thromb Res       Date:  2014-09-06       Impact factor: 3.944

2.  Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer.

Authors:  Bechien U Wu; Jonathan Chang; Christie Y Jeon; Stephen J Pandol; Brian Huang; Eunis W Ngor; Andrew L Difronzo; Robert M Cooper
Journal:  Am J Gastroenterol       Date:  2015-07-21       Impact factor: 10.864

3.  Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

Authors:  M M J Zanders; M P P van Herk-Sukel; P A J Vissers; R M C Herings; H R Haak; L V van de Poll-Franse
Journal:  Br J Cancer       Date:  2015-07-16       Impact factor: 7.640

4.  The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.

Authors:  Christie Y Jeon; Stephen J Pandol; Bechien Wu; Galen Cook-Wiens; Roberta A Gottlieb; C Noel Bairey Merz; Noel Bairey Merz; Marc T Goodman
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

  4 in total
  1 in total

Review 1.  Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.

Authors:  Judith M Graber; Shou-En Lu; Yong Lin; Grace Lu-Yao; Xiang-Lin Tan
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.